Freeline's One Dose Gene Therapy could Transform Hemophilia B Treatment

British scientists have found a potential treatment for people living with hemophilia B.

Results from the Phase I/II trial conducted by researchers from the University College London (UCL), the Royal Free Hospital and Freeline Therapeutics demonstrated the strong possibility that a single injection of FLT180a, an experimental gene therapy, can reduce the frequency of or eliminate the need for weekly injections in people suffering from the disorder.